IPSC
Century TherapeuticsยทNASDAQ
--
--(--)
--
--(--)
IPSC Profile
Century Therapeutics, Inc.
An innovative biotech company that develops induced pluripotent stem cell -derived cell therapies in immuno-oncology
Biological Technology
03/05/2018
06/18/2021
NASDAQ Stock Exchange
78
12-31
Common stock
25 N 38th Street, 11th Floor, Philadelphia, Pennsylvania 19104
--
Century Therapeutics, Inc., was incorporated in Delaware on March 5, 2018. The company is a biotechnology company focused on the development of allogeneic pluripotent stem cell therapies for autoimmune diseases and cancer. Its platform utilizes induced pluripotent stem cells to generate a variety of cell types, including islet beta cells and immune cells, and is engineered with proprietary technology to prevent host immune rejection.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
